You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

16 Results
Guidelines and Advice
Status: Current
ID: 5-2
Version: 2
Oct 2023
Guidelines and Advice
Status: Education and Information
ID: 6-7 Version 2
Version: 2
Jun 2013
Guidelines and Advice
Status: Archived
ID: MOAC 1
Nov 2013
Guidelines and Advice
Status: Archived
ID: 12-7
Jun 2013
Guidelines and Advice
Status: Archived
ID: 12-2 Version 2.2003
Version: 2
May 2013
Guidelines and Advice
Status: Archived
ID: 2-25
Dec 2013
Guidelines and Advice
Status: Archived
ID: 5-1
Apr 2013
Guidelines and Advice
Status: Archived
ID: 6-15
Dec 2013
Guidelines and Advice
Status: Archived
ID: 6-2
Version: 2
Aug 2013
Drug
Other Name(s): Hycamtin®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Apr 2023
Regimen
Cancer Type:
Lung, 
Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
topotecan
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2023
Regimen
Cancer Type:
Gynecologic, 
Ovary
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Bevacizumab (Biosimilar) for Platinum-Resistant Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
topotecan,
bevacizumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Sep 2023

Pages